TW262467B - - Google Patents

Info

Publication number
TW262467B
TW262467B TW083104700A TW83104700A TW262467B TW 262467 B TW262467 B TW 262467B TW 083104700 A TW083104700 A TW 083104700A TW 83104700 A TW83104700 A TW 83104700A TW 262467 B TW262467 B TW 262467B
Authority
TW
Taiwan
Prior art keywords
hydrogen
represented
ocf3
alkoxy
halogen
Prior art date
Application number
TW083104700A
Other languages
English (en)
Chinese (zh)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of TW262467B publication Critical patent/TW262467B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW083104700A 1993-05-27 1994-05-24 TW262467B (en:Method)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6836793A 1993-05-27 1993-05-27
US13932393A 1993-10-19 1993-10-19
US19081494A 1994-02-02 1994-02-02

Publications (1)

Publication Number Publication Date
TW262467B true TW262467B (en:Method) 1995-11-11

Family

ID=27371322

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083104700A TW262467B (en:Method) 1993-05-27 1994-05-24

Country Status (17)

Country Link
EP (1) EP0701551B1 (en:Method)
JP (1) JP3334805B2 (en:Method)
KR (1) KR100314482B1 (en:Method)
CN (1) CN1051302C (en:Method)
AT (1) ATE151750T1 (en:Method)
AU (1) AU681402B2 (en:Method)
CA (1) CA2161768C (en:Method)
DE (1) DE69402703T2 (en:Method)
DK (1) DK0701551T3 (en:Method)
ES (1) ES2103590T3 (en:Method)
FI (1) FI955604L (en:Method)
GR (1) GR3023973T3 (en:Method)
HU (1) HU216633B (en:Method)
IL (1) IL109744A (en:Method)
NO (1) NO306021B1 (en:Method)
TW (1) TW262467B (en:Method)
WO (1) WO1994027964A1 (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8264475B2 (en) 2009-01-05 2012-09-11 Hong Fu Jin Precision Industry (Shenzhen) Co., Ltd. Electronic device with infrared touch input function

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US5563157B1 (en) 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
KR20000048715A (ko) * 1996-09-30 2000-07-25 게리 디. 스트리트, 스티븐 엘. 네스비트 Ｎｍｄａ (ｎ-메틸-ｄ-아스파르테이트) 길항제
CN113419009B (zh) * 2021-06-29 2023-02-07 国家烟草质量监督检验中心 一种氟噻虫砜代谢物的液相色谱串联质谱测定方法
CN113419008B (zh) * 2021-06-29 2023-02-07 国家烟草质量监督检验中心 一种氟噻虫砜代谢物的合相色谱串联质谱测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
WO2019021625A1 (ja) * 2017-07-25 2019-01-31 株式会社日立ハイテクノロジーズ 自動分析装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8264475B2 (en) 2009-01-05 2012-09-11 Hong Fu Jin Precision Industry (Shenzhen) Co., Ltd. Electronic device with infrared touch input function

Also Published As

Publication number Publication date
EP0701551B1 (en) 1997-04-16
GR3023973T3 (en) 1997-10-31
HU216633B (hu) 1999-07-28
JPH09508615A (ja) 1997-09-02
CN1124484A (zh) 1996-06-12
JP3334805B2 (ja) 2002-10-15
CN1051302C (zh) 2000-04-12
WO1994027964A1 (en) 1994-12-08
KR960702438A (ko) 1996-04-27
IL109744A (en) 1999-06-20
FI955604A7 (fi) 1995-11-21
NO306021B1 (no) 1999-09-06
CA2161768C (en) 1998-08-18
HUT74620A (en) 1997-01-28
HU9503367D0 (en) 1996-01-29
ATE151750T1 (de) 1997-05-15
KR100314482B1 (ko) 2002-02-28
CA2161768A1 (en) 1994-12-08
DE69402703T2 (de) 1997-11-27
EP0701551A1 (en) 1996-03-20
NO954769L (no) 1996-01-25
NO954769D0 (no) 1995-11-24
FI955604A0 (fi) 1995-11-21
AU6784394A (en) 1994-12-20
IL109744A0 (en) 1994-08-26
ES2103590T3 (es) 1997-09-16
DK0701551T3 (da) 1997-10-20
FI955604L (fi) 1995-11-21
AU681402B2 (en) 1997-08-28
DE69402703D1 (de) 1997-05-22

Similar Documents

Publication Publication Date Title
IE892340L (en) 4-oxoquinoline-3-carboxylic acid derivatives, their¹preparation and their use
GR3020715T3 (en) Xanthine compounds
AU8345491A (en) Heterocyclic derivatives
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
IE811085L (en) Pyridoxine derivatives
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
TW262467B (en:Method)
IE861633L (en) Carboxamide indole derivatives
EP0351255A3 (en) Derivatives of û2-(4-piperidinyl)methyl¨-1,2,3,4-tetrahydroisoquinoline, their preparation and their use in therapy
ES8609212A1 (es) Un procedimiento para la preparacion de derivados de etanolamina.
GB2334032A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
MX9206930A (es) Nuevos compuestos
TW334428B (en) Novel benzodiazepine derivatives
SE8705196D0 (sv) Pyrimidinderivat
TW336232B (en) Indol-3-yl propenoic acid derivatives for antagonizing NMDA(N-methyl-D-aspartate) and pharmaceutical compositions thereof
NZ291855A (en) Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists
CA2245484A1 (en) Novel urea derivatives
AU4932590A (en) Cyclic guanidines uses as calcium antagonists
GB8515212D0 (en) Thiazolidine derivatives
DE3467297D1 (en) Benzobicyclononane amino derivatives with anticonvulsive properties
TW326439B (en) Octahydornaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use